Provention Bio, Inc.

TZIELD

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Provention Bio, Inc.

Tzield HCPCS:

J9381

HCPCS Code Descriptor:

Injection, teplizumab-mzwv, 5 mcg

Category:

J Code

Tzield NDCs:

73650-0316-14, 73650-0316-10, 73650-0316-01

Primary Type:

Insulin

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Tzield CPT Codes:

Potential CPT administration codes for Tzield can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

73650-0316-14, 73650-0316-10

About Tzield:

TZIELD is a Insulin drug manufactured by Provention Bio, Inc. and administered via the Intravenous route of administration. The J Code: J9381 is aligned to the drug TZIELD.

TZIELD belongs to the class of drugs known as monoclonal antibodies. It works by binding to the CD3 protein on T cells and can be used to delay the symptoms of a certain type of diabetes. TZIELD is manufactured by Provention Bio and is aligned to the HCPCS code J9381.

ACCESS PRICING AND MORE BY REGISTERING

J9381 Added Date:

July 1, 2023

J9381 Effective Date:

July 1, 2023

J9381 Termination Date:

HCPCS Active

Tzield billing and coding information can be found through Provention Bio, Inc. at the link below:
Tzield patient assistance information can be found through Provention Bio COMPASS at the URL: https://www.tzieldhcp.com/patient-support
TZIELD prescribing information can be found at the link below:
Information regarding TZIELD’s side effects can be found at MedlinePlus